Position in BMY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$963,291
-$139,750 QoQ
Shares Held
16,718
-8.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,185
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $38,982,476 across 11 Drug Manufacturers - General names. BMY ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
32,392 | $8,151,122 | |
| 2 | JNJ |
Johnson & Johnson
|
30,495 | $7,744,815 | |
| 3 | LLY |
ELI LILLY & Co
|
6,408 | $7,685,948 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,916 | $6,542,706 | |
| 5 | AMGN |
Amgen Inc
|
6,850 | $2,480,522 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,103 | $2,160,793 | |
| 7 | PFE |
Pfizer Inc
|
55,347 | $1,332,755 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
16,718 | $963,291 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963,291 | 16,718 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,103,041 | 18,187 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $833,480 | 15,452 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,614,625 | 35,801 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,244,923 | 26,894 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,733,518 | 28,423 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,055,409 | 18,660 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $891,842 | 17,237 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $692,097 | 16,665 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $802,983 | 14,807 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $472,667 | 9,212 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $787,138 | 13,562 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $730,756 | 11,427 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $688,941 | 9,940 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $761,590 | 10,585 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $655,449 | 9,220 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $922,152 | 11,976 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,140,874 | 15,622 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $665,648 | 10,676 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $303,423 | 5,128 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $338,576 | 5,067 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $362,555 | 5,743 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $374,723 | 6,041 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $371,326 | 6,159 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $360,914 | 6,138 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $322,232 | 5,781 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||